Angelova A - Search Results

1

The Complex Role of Infectious Agents in Human Cutaneous T-Cell Lymphoma Pathogenesis: From Candidate Etiological Factors to Potential Therapeutics.

Angelova A, Rommelaere J, Ungerechts G. Angelova A, et al. Pathogens. 2024 Feb 20;13(3):184. doi: 10.3390/pathogens13030184. Pathogens. 2024. PMID: 38535528 Free PMC article. Review.

2

Generation and Validation of Monoclonal Antibodies Suitable for Detecting and Monitoring Parvovirus Infections.

Tessmer C, Plotzky C, Fees J, Welsch H, Eudenbach R, Faber M, Simón A, Angelova A, Rommelaere J, Hofmann I, Nüesch JPF. Tessmer C, et al. Among authors: angelova a. Pathogens. 2022 Feb 4;11(2):208. doi: 10.3390/pathogens11020208. Pathogens. 2022. PMID: 35215151 Free PMC article.

3

Oncolytic Rodent Protoparvoviruses Evade a TLR- and RLR-Independent Antiviral Response in Transformed Cells.

Angelova A, Pierrard K, Detje CN, Santiago E, Grewenig A, Nüesch JPF, Kalinke U, Ungerechts G, Rommelaere J, Daeffler L. Angelova A, et al. Pathogens. 2023 Apr 17;12(4):607. doi: 10.3390/pathogens12040607. Pathogens. 2023. PMID: 37111493 Free PMC article.

4

Oncolytic rat parvovirus H-1PV, a candidate for the treatment of human lymphoma: In vitro and in vivo studies.

Angelova AL, Aprahamian M, Balboni G, Delecluse HJ, Feederle R, Kiprianova I, Grekova SP, Galabov AS, Witzens-Harig M, Ho AD, Rommelaere J, Raykov Z. Angelova AL, et al. Mol Ther. 2009 Jul;17(7):1164-72. doi: 10.1038/mt.2009.78. Epub 2009 Apr 14. Mol Ther. 2009. PMID: 19367260 Free PMC article.

5

Immune System Stimulation by Oncolytic Rodent Protoparvoviruses.

Angelova A, Rommelaere J. Angelova A, et al. Viruses. 2019 May 4;11(5):415. doi: 10.3390/v11050415. Viruses. 2019. PMID: 31060205 Free PMC article. Review.

6

Parvovirus-Based Combinatorial Immunotherapy: A Reinforced Therapeutic Strategy against Poor-Prognosis Solid Cancers.

Angelova A, Ferreira T, Bretscher C, Rommelaere J, Marchini A. Angelova A, et al. Cancers (Basel). 2021 Jan 19;13(2):342. doi: 10.3390/cancers13020342. Cancers (Basel). 2021. PMID: 33477757 Free PMC article. Review.

7

Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcinoma.

Hajda J, Leuchs B, Angelova AL, Frehtman V, Rommelaere J, Mertens M, Pilz M, Kieser M, Krebs O, Dahm M, Huber B, Engeland CE, Mavratzas A, Hohmann N, Schreiber J, Jäger D, Halama N, Sedlaczek O, Gaida MM, Daniel V, Springfeld C, Ungerechts G. Hajda J, et al. Among authors: angelova al. Clin Cancer Res. 2021 Oct 15;27(20):5546-5556. doi: 10.1158/1078-0432.CCR-21-1020. Epub 2021 Aug 23. Clin Cancer Res. 2021. PMID: 34426438 Clinical Trial.

8

Anticancer effects of an oncolytic parvovirus combined with non-conventional therapeutics on pancreatic carcinoma cell lines.

Raykov Z, Georgieva PB, Angelova A, Galabov AS, Rommelaere J. Raykov Z, et al. Among authors: angelova a. Acta Virol. 2009;53(1):57-60. doi: 10.4149/av_2009_01_57. Acta Virol. 2009. PMID: 19301953

9

Oncolytic parvoviruses as cancer therapeutics.

Rommelaere J, Geletneky K, Angelova AL, Daeffler L, Dinsart C, Kiprianova I, Schlehofer JR, Raykov Z. Rommelaere J, et al. Cytokine Growth Factor Rev. 2010 Apr-Jun;21(2-3):185-95. doi: 10.1016/j.cytogfr.2010.02.011. Epub 2010 Mar 7. Cytokine Growth Factor Rev. 2010. PMID: 20211577 Review.

10

Oncolytic parvoviruses: from basic virology to clinical applications.

Marchini A, Bonifati S, Scott EM, Angelova AL, Rommelaere J. Marchini A, et al. Among authors: angelova al. Virol J. 2015 Jan 29;12:6. doi: 10.1186/s12985-014-0223-y. Virol J. 2015. PMID: 25630937 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

139 results

Search Page